Cabergoline and mitral valve incompetence 
Cabergoline and mitral valve incompetence Patient Reports February 12, 2012
Cabergoline Side Effects Report #4680055-X
Cabergoline side effect was reported by a Physician from on May 17, 2005. Female patient, 61 years of age, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, cardiac murmur, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with PERMAX. Patient recovered.
Cabergoline Side Effects Report #4688540-1
Cabergoline side effect was reported by a Physician from on May 27, 2005. Female patient, 61 years of age, was diagnosed with restless legs syndrome, rheumatic fever and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic atherosclerosis, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with PERMAX. Patient recovered.
Cabergoline Side Effects Report #5082036-3
Cabergoline side effect was reported by a Physician from GERMANY on Aug 01, 2006. Male patient, 54 years of age, weighting 154.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, asthenia, dilatation ventricular, ejection fraction decreased, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: 1 MG (1 IN 1 D), ORAL. During the same period patient was treated with CARVEDILOL, DIOVAN HCT, SPIRONOLACTONE, ZOCOR, TORSEMIDE. Patient recovered.
Cabergoline Side Effects Report #4656532-4
Cabergoline side effect was reported by a Physician from on Apr 22, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, endocarditis
, hyperkinetic heart syndrome, mitral valve incompetence. Cabergoline dosage: 4 MG , ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #4680723-X
Cabergoline side effect was reported by a Physician from on May 19, 2005. Female patient, weighting 132.3 lb, was diagnosed with restless legs syndrome and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dyspnoea exertional, endocarditis
, fatigue, hyperkinesia, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with RESTEX, MADOPAR. Patient recovered.Cabergoline Side Effects Report #5353079-7
Cabergoline side effect was reported by a Physician from UNITED KINGDOM on May 30, 2007. Female patient was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #6004852-3
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with prolactinoma and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiac aneurysm, cardiac valve disease, dyspnoea, mitral valve incompetence, ventricular tachycardia. Cabergoline dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, ATENOLOL, ACETAMINOPHEN W, CREON, DOMPERIDONE, ENALAPRIL MALEATE, FERROUS SULPHATE, FLUOXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5055245-7
Cabergoline side effect was reported by a Physician from JAPAN on June 28, 2006. Female patient, 79 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure acute, dilatation ventricular, mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.
Cabergoline Side Effects Report #4825201-X
Cabergoline side effect was reported by a Physician from SPAIN on Nov 03, 2005. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac valve disease, cardiomegaly, dilatation atrial, mitral valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4934700-1
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2006. Male patient, 74 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cardiac murmur, cardiac valve disease, cardiomegaly, dilatation atrial, gallop rhythm present, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (2 MG, 2 IN 1 D). Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4600814-9
Cabergoline side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 64 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, mitral valve incompetence, pleural disorder
. Cabergoline dosage: (6 MG), ORAL. During the same period patient was treated with PERGOLIDE, SINEMET, AMANTADINE. Patient recovered.Cabergoline Side Effects Report #5502491-1
Cabergoline side effect was reported by a Physician from GERMANY on Oct 18, 2007. Female patient, weighting 132.3 lb, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, left ventricular dysfunction, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence. Cabergoline dosage: DAILY DOSE:10MG. Patient recovered.
Cabergoline Side Effects Report #5127987-6
Cabergoline side effect was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5414055-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2007. Female patient, 81 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #4966139-7
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis, dilatation atrial, left ventricular failure, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMANTADINE, NACOM. Patient recovered.Cabergoline Side Effects Report #5738139-0
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on May 02, 2008. Male patient, 76 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5094391-9
Cabergoline side effect was reported by a Physician from GERMANY on Aug 16, 2006. Female patient, 75 years of age, weighting 176.4 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, hypertensive heart disease, mitral valve incompetence. Cabergoline dosage: 2 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR, BISOPROLOL, HYDROCHLOROTHIAZIDE. Patient recovered.Cabergoline Side Effects Report #5608635-5
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Jan 20, 2008. Female patient, 75 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac arrest , cardiogenic shock, chest pain , dyspnoea, hypotension, mitral valve incompetence, mitral valve sclerosis. Cabergoline dosage: DAILY DOSE:4MG. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #5085990-9
Cabergoline side effect was reported by a Physician from JAPAN on Aug 02, 2006. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, condition aggravated, disseminated intravascular coagulation, dyspnoea, mitral valve incompetence, oedema peripheral, pulmonary hypertension , pulmonary oedema, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with LEVODOPA. Patient was hospitalized. Patient died.Cabergoline Side Effects Report #4626909-1
Cabergoline side effect was reported by a Physician from on Mar 21, 2005. Female patient, 74 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure acute, diarrhoea, dilatation atrial, hypertension, mitral valve incompetence, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5094396-8
Cabergoline side effect was reported by a Physician from DENMARK on Aug 16, 2006. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, dyspnoea, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.Cabergoline Side Effects Report #4688270-6
Cabergoline side effect was reported by a Physician from on May 27, 2005. Male patient, 73 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, dyspnoea, fibrosis, mitral valve incompetence, mitral valve sclerosis, pleural fibrosis. Cabergoline dosage: 6 MG (DAILY), ORAL. During the same period patient was treated with CORODIL, COMTESS, SINEMET. Patient recovered.Cabergoline Side Effects Report #4645346-7
Cabergoline side effect was reported by a Physician from on Apr 11, 2005. Male patient, 72 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: akinesia, aortic valve incompetence, blood pressure systolic increased, cardiac failure, cardiomegaly, dilatation atrial, dyspnoea exertional, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 2 MG , ORAL. During the same period patient was treated with SELEGILINE HYDROCHLORIDE, TRIHEXYPHENIDYL, AMLODIPINE BESYLATE, SINEMET, MADOPAR, ETIZOLAM, DROXIDOPA. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5401755-X
Cabergoline side effect was reported by a Physician from JAPAN on July 19, 2007. Female patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence. Cabergoline dosage: DAILY DOSE:1MG. Patient recovered.Cabergoline Side Effects Report #4870603-9
Cabergoline side effect was reported by a Physician from GERMANY on Dec 19, 2005. Male patient, 71 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, left ventricular failure, mitral valve incompetence, pleural effusion, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with LEVODOPA, AMANTADINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4931079-6
Cabergoline side effect was reported by a Physician from GERMANY on Feb 13, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4960888-2
Cabergoline side effect was reported by a Physician from GERMANY on Mar 14, 2006. Male patient, 71 years of age, weighting 163.1 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic dilatation, aortic valve incompetence, aortic valve sclerosis, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 6 MG (2 MG, 2 IN 1 D), ORAL. During the same period patient was treated with STALEVO, AMANTADINE, ACETYLSALICYLIC ACID SRT. Patient recovered.Cabergoline Side Effects Report #4659075-7
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Female patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4659129-5
Cabergoline side effect was reported by a Health Professional from on Apr 26, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: (3 MG), ORAL. During the same period patient was treated with SINEMET, ATORVASTATIN CALCIUM, LEVOTHYROXINE, LAMOTRIGINE, ZOPICLONE. Patient recovered.Cabergoline Side Effects Report #4629438-4
Cabergoline side effect was reported by a Physician from on Mar 24, 2005. Male patient, 69 years of age, weighting 167.6 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: activities of daily living impaired, aortic valve incompetence, cardiac failure, cardiac valve disease, cardiomegaly, condition aggravated, echocardiogram abnormal, mitral valve incompetence, palpitations. Cabergoline dosage: unknown. During the same period patient was treated with PERGOLIDE MESYLATE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4917899-2
Cabergoline side effect was reported by a Consumer or non-health professional from SWEDEN on Feb 06, 2006. Female patient, 69 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac murmur, mitral valve incompetence, nightmare, pulmonary hypertension , tricuspid valve incompetence, visual disturbance. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with ZOLOFT, MADOPARK, TOLTERODINE TARTRATE. Patient recovered.Cabergoline Side Effects Report #4596675-7
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient, 68 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: amaurosis fugax, aortic injury, aortic valve incompetence, cardiac failure, condition aggravated, left ventricular failure, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, QD), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE, FUROSEMIDE, AMILORIDE W, LEVODOPA W, CLOPIDOGREL BISULPHATE, CITALOPRAM, PAROXETINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4742129-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on July 25, 2005. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, fibrosis, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 6 MG (EVERY DAY), ORAL. During the same period patient was treated with GLUCOSAMINE, AMANTADINE. Patient recovered.Cabergoline Side Effects Report #4920575-3
Cabergoline side effect was reported by a Health Professional from SWEDEN on Feb 06, 2006. Male patient, 68 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, dementia , dilatation atrial, hallucination, hypotension, mitral valve incompetence, orthostatic hypotension, pulmonary arterial pressure increased. Cabergoline dosage: 8 MG (1 D), ORAL. During the same period patient was treated with ARICEPT, EMCONCOR, MADOPARK, MADOPARK QUICK, EXELON, EDRONAX, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #5176562-6
Cabergoline side effect was reported by a Physician from JAPAN on Nov 24, 2006. Female patient, 67 years of age, weighting 84.66 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aortic valve incompetence, aspartate aminotransferase increased, blood lactate dehydrogenase increased, chest discomfort, leukaemia, malaise, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4 MG (1 D), ORAL. During the same period patient was treated with LUVOX, JUVELA NICOTINATE, CEROCRAL, RIZE, KOLANTYL, ULCERMIN, GRAMALIL, HYDREA. Patient was hospitalized. Patient died on 10/22/2006.Cabergoline Side Effects Report #4577451-8
Cabergoline side effect was reported by a Physician from on Jan 26, 2005. Male patient, 66 years of age, weighting 121.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, dizziness , dyspnoea, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG (2 MG, ) , ORAL. During the same period patient was treated with MADOPAR, ENTACAPNE. Patient recovered.Cabergoline Side Effects Report #4779043-4
Cabergoline side effect was reported by a Physician from SWEDEN on Sept 12, 2005. Male patient, 66 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, atrial fibrillation , blood pressure increased, cardiac murmur, erectile dysfunction , eye disorder, hallucination, visual, mitral valve incompetence, myocardial infarction. Cabergoline dosage: 0.5 MG (DAILY); ORAL. During the same period patient was treated with TOLTERODINE TARTRATE, ASPIRIN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4597043-4
Cabergoline side effect was reported by a Health Professional from on Feb 16, 2005. Female patient, 65 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4686425-8
Cabergoline side effect was reported by a Health Professional from on May 25, 2005. Female patient, 64 years of age, weighting 116.0 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary oedema. Cabergoline dosage: (6 MG), ORAL. During the same period patient was treated with FUROSEMIDE, RAMIPRIL. Patient recovered.Cabergoline Side Effects Report #4933991-0
Cabergoline side effect was reported by a Physician from GERMANY on Feb 21, 2006. Female patient, 64 years of age, weighting 160.9 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, hypertension, mitral valve incompetence, pulmonary valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 8 MG (4 MG, 2 IN 1 D), ORAL. During the same period patient was treated with AMANTADINE, LEVOTHYROXINE, PRESOMEN COMPOSITUM, LISINOPRIL, DIOVAN HCT, BISOPROLOL, NITRENDIPINE, SIMVASTATIN. Patient recovered.Cabergoline Side Effects Report #4896417-1
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Jan 17, 2006. Female patient, 62 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (4 MG, EVERY DAY), ORAL. During the same period patient was treated with FUROSEMIDE, PERINDOPRIL, SPIRONOLACTONE, SALMETEROL, SALBUTAMOL. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659082-4
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Female patient, 61 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence. Cabergoline dosage: 6 MG (DAILY),ORAL. During the same period patient was treated with SINEMET, PAROXETINE. Patient recovered.Cabergoline Side Effects Report #5154439-X
Cabergoline side effect was reported by a Physician from GERMANY on Nov 02, 2006. Male patient, 60 years of age, weighting 165.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, dyspnoea exertional, mitral valve incompetence. Cabergoline dosage: 12 MG, ORAL. During the same period patient was treated with COMTESS, SINEMET. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4638459-7
Cabergoline side effect was reported by a Physician from on Apr 04, 2005. Male patient, 58 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: fibrosis, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG 96 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SINEMET, SELEGILINE HYDROCHLORIDE, SIMVASTATIN, TRANDOLAPRIL, RISPERDAL, AMIODARONE, FUROSEMIDE, CARVEDILOL. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4987994-0
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Apr 19, 2006. Male patient, 58 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial fibrillation , cardiac failure, cardiac procedure complication, mitral valve incompetence, mitral valve sclerosis, tricuspid valve incompetence, tricuspid valve sclerosis. Cabergoline dosage: 6 MG (6 MG, 1 D), ORAL. During the same period patient was treated with SINEMET, ELDEPRYL, SIMVASTATIN, ODRIK, SPIRONOLACTONE, CORDARONE, FUROSEMIDE, DIMITONE. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4710055-2
Cabergoline side effect was reported by a Physician from ITALY on June 23, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with MANTADAN. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4886854-3
Cabergoline side effect was reported by a Physician from GERMANY on Jan 09, 2006. Male patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arteriosclerosis, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, PARKINSAN, UROXATRAL. Patient recovered.Cabergoline Side Effects Report #4932515-1
Cabergoline side effect was reported by a Physician from GERMANY on Feb 21, 2006. Male patient, 57 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, carotid artery atheroma, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with MADOPAR, PARKINSAN, UROXATRAL. Patient recovered.Cabergoline Side Effects Report #4765597-0
Cabergoline side effect was reported by a Physician from SPAIN on Aug 24, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 6 MG (DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET, STALEVO, BESITRAN. Patient recovered.Cabergoline Side Effects Report #4850529-7
Cabergoline side effect was reported by a Physician from SPAIN on Nov 30, 2005. Male patient, 55 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood lactate dehydrogenase increased, cardiomegaly, haemoptysis, mitral valve incompetence, nasopharyngitis, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with AMANTADINE, DILUTOL, MOTILIUM, SINEMET, STALEVO, BESITRAN. Patient recovered.Cabergoline Side Effects Report #5524322-6
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Nov 12, 2007. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, SINEMET CR, ZELAPAR. Patient recovered.Cabergoline Side Effects Report #5657296-8
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Feb 27, 2008. Female patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, condition aggravated, heart valve incompetence, left atrial dilatation, mitral valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with REQUIP, SINEMET, SINEMET CR, ZELAPAR. Patient recovered.Cabergoline Side Effects Report #4965978-6
Cabergoline side effect was reported by a Health Professional from NORWAY on Mar 24, 2006. Male patient, 54 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiomyopathy , mitral valve incompetence. Cabergoline dosage: 6 MG (6 MG, 1 IN 1 D), ORAL. During the same period patient was treated with STALEVO. Patient recovered.Cabergoline Side Effects Report #4659579-7
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Female patient, 52 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG (DAILY), ORAL. Patient recovered.Cabergoline Side Effects Report #4659081-2
Cabergoline side effect was reported by a Physician from on Apr 26, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4664720-6
Cabergoline side effect was reported by a Physician from on May 06, 2005. Male patient, 51 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 12 MG (DAILY), ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #5150532-6
Cabergoline side effect was reported by a Physician from SPAIN on Oct 26, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: atrial hypertrophy, electrocardiogram st segment depression, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #5161996-6
Cabergoline side effect was reported by a Physician from SPAIN on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #4931009-7
Cabergoline side effect was reported by a Physician from SPAIN on Feb 14, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease
, ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.Cabergoline Side Effects Report #4659584-0
Cabergoline side effect was reported by a Physician from on Apr 27, 2005. Male patient, 44 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 6 MG DAILY ORAL. Patient recovered.Cabergoline Side Effects Report #4674025-5
Cabergoline side effect was reported by a Health Professional from on May 12, 2005. Female patient, 44 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence, pulmonary hypertension . Cabergoline dosage: 4 M G (4 MG, DAILY INTERVAL: EVERY DAY) ORAL. During the same period patient was treated with SINEMET CR. Patient recovered.Cabergoline Side Effects Report #5104134-8
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 28, 2006. Female patient, 41 years of age, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, mitral valve incompetence, mitral valve stenosis, obstruction, obstructive airways disorder, total lung capacity decreased. Cabergoline dosage: 4 MG (DAILY), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.Cabergoline Side Effects Report #5133242-0
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, aortic valve incompetence, aortic valve sclerosis, dilatation ventricular, mitral valve incompetence, mitral valve prolapse, mitral valve sclerosis, oedema peripheral, treatment noncompliance. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5478685-0
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on Sept 25, 2007. Female patient, weighting 90.39 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic stenosis, aortic valve incompetence, cardiac failure congestive, heart valve calcification, mitral valve incompetence. Cabergoline dosage: DAILY DOSE:4MG. During the same period patient was treated with PERMAX, PERGOLIDE MESYLATE, MADOPAR, ARTANE, ADALAT, RYTHMODAN, LASIX, GASMOTIN. Patient recovered.Cabergoline Side Effects Report #6025156-9
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Dec 16, 2008. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: alopecia, aortic valve incompetence, arrhythmia , delusion, dyspnoea, fatigue, hypertension, mitral valve incompetence, oedema peripheral. Cabergoline dosage: 4MG PER DAY. During the same period patient was treated with NACOM. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6104206-5
Cabergoline side effect was reported by a Physician from SPAIN on Feb 20, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6115183-5
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6121725-6
Cabergoline side effect was reported by a Health Professional from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #6124995-3
Cabergoline side effect was reported by a Physician from SPAIN on Mar 04, 2009. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bundle branch block right, cardiac murmur, mitral valve incompetence, pleural effusion, pulmonary hypertension , tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with LEVODOPA, METHYLPHENIDATE HYDROCHLORIDE, RASAGILINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4565809-2
Cabergoline side effect was reported by a Physician from on Jan 17, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cough, dyspnoea, mitral valve incompetence, oedema. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR. Patient recovered.Cabergoline Side Effects Report #4575789-1
Cabergoline side effect was reported by a Physician from on Jan 24, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure increased, dyspnoea, dyspnoea exertional, face oedema, histology abnormal, mitral valve disease, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR, ACETYLSALICYLIC ACID SRT, ZUMESTON. Patient recovered.Cabergoline Side Effects Report #4579898-2
Cabergoline side effect was reported by a Physician from on Jan 28, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, mitral valve incompetence, orthopnoea, parkinson's disease . Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with MADOPAR, MESALAMINE. Patient was hospitalized. Patient recovered.Cabergoline Side Effects Report #4659586-4
Cabergoline side effect was reported by a Physician from on Apr 29, 2005. Female patient was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, mitral valve incompetence. Cabergoline dosage: 6 MG, ORAL. During the same period patient was treated with SINEMET. Patient recovered.Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #4765276-X
Cabergoline side effect was reported by a Physician from GERMANY on Aug 26, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease
and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, coronary artery disease , mitral valve incompetence, mitral valve sclerosis, pleural effusion, pneumonia , pulmonary congestion, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with SELEGELINE HYDROCHLORIDE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.Cabergoline Side Effects Report #5100675-8
Cabergoline side effect was reported by a Consumer or non-health professional from DENMARK on Aug 24, 2006. Female patient, 60 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bradycardia, cardiac procedure complication, chest discomfort, dyspnoea, electrocardiogram abnormal, heart rate irregular, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: 10 MG DAILY, ORAL. During the same period patient was treated with GABAPENTIN, SINEMET, PAMOL, MANDOLGIN, REQUIP, CENTYL MITE W, PERMAX, SIFROL. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4567733-8
Cabergoline side effect was reported by a Physician from on Jan 14, 2005. Female patient, 60 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bradycardia, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: 10 MG (DAILY), ORAL. During the same period patient was treated with GABAPENTIN, SINEMET, ACETAMINOPHEN, TRAMADOL, ROPINIROLE HYDROCHLORIDED, SALURES. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #4596813-6
Cabergoline side effect was reported by a Physician from on Feb 14, 2005. Female patient, 60 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: bradycardia, mitral valve incompetence, mitral valve stenosis. Cabergoline dosage: 10 MG (DAILY), ORAL. During the same period patient was treated with GABAPENTIN, SINEMET, ACETAMINOPHEN, TRAMADOL, ROPINIROLE HYDROCHLORIDE, SALURES. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5273373-8
Cabergoline side effect was reported by a Physician from SPAIN on Mar 09, 2007. Female patient, 49 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, mitral valve incompetence. Cabergoline dosage: 5 MG QDAY. Patient recovered.
Cabergoline Side Effects Report #5218471-X
Cabergoline side effect was reported by a Physician from GERMANY on Jan 04, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, arrhythmia
, cardiac valve disease, chest pain , dyspnoea, mitral valve incompetence, oedema, syncope, tricuspid valve incompetence. Cabergoline dosage: unknown. Patient recovered.Cabergoline Side Effects Report #5298356-3
Cabergoline side effect was reported by a Physician from ITALY on Mar 27, 2007. Female patient was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, cardiac failure, mitral valve incompetence. Cabergoline dosage: unknown. Patient recovered.